These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Catatonia and psychosis associated with sibutramine: a case report and pathophysiologic correlation. Lee J; Teoh T; Lee TS J Psychosom Res; 2008 Jan; 64(1):107-9. PubMed ID: 18158006 [TBL] [Abstract][Full Text] [Related]
4. A case of psychosis associated with Pai You Guo slimming capsules containing sibutramine. Shah KA; Abraham MA; Espinosa JB J Clin Psychiatry; 2015 Jul; 76(7):e893-4. PubMed ID: 26231019 [No Abstract] [Full Text] [Related]
5. Tolerability of sibutramine during a 6-week treatment period in high-risk patients with cardiovascular disease and/or diabetes: a preliminary analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial. Maggioni AP; Caterson I; Coutinho W; Finer N; Gaal LV; Sharma AM; Torp-Pedersen C; Bacher P; Shepherd G; Sun R; James P; J Cardiovasc Pharmacol; 2008 Nov; 52(5):393-402. PubMed ID: 19033818 [TBL] [Abstract][Full Text] [Related]
6. Controversy about the cardiovascular safety of sibutramine. Scheen AJ Drug Saf; 2010 Jul; 33(7):615-8. PubMed ID: 20553062 [No Abstract] [Full Text] [Related]
7. Misuse of sibutramine and bulimia nervosa: a dangerous combination. Ferreira GM; Nazar BP; da Silva MR; Carriello MA; Freitas S; Appolinario JC Braz J Psychiatry; 2018; 40(3):343. PubMed ID: 30043896 [No Abstract] [Full Text] [Related]
8. [Adverse drug reactions of a slimming product contaminated with sibutramine]. van Hunsel F; van Grootheest K Ned Tijdschr Geneeskd; 2011; 155(42):A3695. PubMed ID: 22027464 [TBL] [Abstract][Full Text] [Related]
9. Sibutramine-associated psychosis (case report). Gazdag G; Szabó Z Neuropsychopharmacol Hung; 2008 May; 10(2):107-10. PubMed ID: 18959143 [TBL] [Abstract][Full Text] [Related]
10. [The anti-obesity drug sibutramine for overweight diabetic patients. "Blood pressure is not elevated")]. Matiba B MMW Fortschr Med; 2002 Jul; 144(27-28):16; author reply 17. PubMed ID: 12198873 [No Abstract] [Full Text] [Related]
17. Sibutramine: an Australian analysis of reported adverse effects. Prescrire Int; 2007 Jun; 16(89):114. PubMed ID: 17590911 [No Abstract] [Full Text] [Related]
18. European Medicines Agency withdrawal for sibutramine. Galhardo J; Davis N; Matthai S; Shield JP Arch Dis Child; 2010 Oct; 95(10):856. PubMed ID: 20573736 [No Abstract] [Full Text] [Related]
19. [Abuse potential of sibutramine]. Saiz Ruiz J; Saiz González D; Antón Fructuoso P Med Clin (Barc); 2003 May; 120(16):639. PubMed ID: 12732133 [No Abstract] [Full Text] [Related]
20. Bruising associated with sibutramine: results from postmarketing surveillance in New Zealand. Harrison-Woolrych M; Hill GR; Clark DW Int J Obes (Lond); 2006 Aug; 30(8):1315-7. PubMed ID: 16491106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]